Frailty has been associated with a risk of adverse outcomes, and mortality in patients with various conditions. However, there have been few studies on whether or not frailty is associated with mortality in patients with accidental hypothermia (AH). In this study, we aim to determine this association in patients with AH using Japan’s nationwide registry data.
Methods
The data from the Hypothermia STUDY 2018&19, which included patients of ≥18 years of age with a body temperature of ≤35 °C, were obtained from a multicenter registry for AH conducted at 120 institutions throughout Japan, collected from December 2018 to February 2019 and December 2019 to February 2020. The clinical frailty scale (CFS) score was used to determine the presence and degree of frailty. The primary outcome was the comparison of mortality between the frail and non-frail patient groups.
Results
In total, 1363 patients were included in the study, of which 920 were eligible for the analysis. The 920 patients were divided into the frail patient group (N = 221) and non-frail patient group (N = 699). After 30-days of hospitalization, 32.6% of frail patients and 20.6% of non-frail patients had died (p < 0.001). Frail patients had a significantly higher risk of 90-day mortality (Hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.25–2.17; p < 0.001). Based on the Cox proportional hazards analysis using multiple imputation, after adjustment for age, potassium level, lactate level, pH value, sex, CPK level, heart rate, platelet count, location of hypothermia incidence, and rate of tracheal intubation, the HR was 1.69 (95% CI, 1.25–2.29; p < 0.001).
Conclusions
This study showed that frailty was associated with mortality in patients with AH. Preventive interventions for frailty may help to avoid death caused by AH.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AH
Accidental hypothermia
CFS
Clinical frailty scale
HR
Hazard ratio
CI
Confidence interval
EMS
Emergency medical services
ED
Emergency department
ADL
Activities of daily living
CCI
Charlson comorbidity index
GCS
Glasgow coma scale
SOFA
Sequential Organ Failure Assessment
CPC
Cerebral Performance Category
ECMO
Extracorporeal membrane oxygenation
ICU
Intensive care unit
CT
Computed tomography
Background
The incidence of accidental hypothermia (AH), which is defined by a body core temperature of < 35 °C [1], is low, however, severe hypothermia is associated with a high mortality rate [2, 3]. In severe hypothermia, intrinsic heat production by means of active movement and shivering, disappeared, leading to further progression in the decrease in body temperature. In Japan, which has a large elderly population, the mortality rate of all patients with AH is as high as 24.4–35% [4, 5], so effective prevention and intervention strategies are required.
Frailty is characterized by a decline in functioning across multiple physiological systems, accompanied by an increased vulnerability to stressors [6]. More recently, data have suggested that the presence of frailty places a person at increased risk of adverse outcomes, including hospitalization, and mortality [7]. Recently, frailty has also been noted in critically ill patients [8, 9]. However, to our knowledge, limited data exist regarding the relationship between AH and frailty. Clarification of the relationship between AH and frailty may provide useful insight for improving the prognosis of patients with hypothermia.
Anzeige
We hypothesized that frailty would be associated with a poor prognosis and mortality in patients with AH. For the purpose of verifying this hypothesis, we analyzed the Japan’s nationwide registry data on hypothermia.
Material and methods
Study design and setting
We performed a prospective, observational, multi-center registries of hypothermia: the Hypothermia STUDY 2018&2019. This study was conducted from December 2018 to February 2019 and December 2019 to February 2020, among a consortium of 120 academic and community medical centers from different geographic regions across Japan. The study has been approved by the Ethics Review Board of Teikyo University Hospital in Japan (Approval No: 17–090). The requirement for informed consent was waived due to the observational nature of the study by the Ethics Review Board of Teikyo University Hospital in Japan. In addition, the institutional review board of each hospital listed in the acknowledgements approved the study.
Patient selection and data collection
The present study included consecutive patients whose body temperature, as measured by emergency medical services (EMS) or at the emergency department (ED), was < 35 °C. Patients of < 18 years of age were excluded. The following data were collected: age, sex, any pre-existing conditions, activities of daily living (ADL), lifestyle, location of hypothermia incidence, mechanism underlying hypothermia (acute medical illness [stroke, ischemic cardiac disease, infectious disease, malnutrition, arrhythmia, diabetes mellitus, renal disease, hypoglycemia, cardiac failure, endocrine disease and gastrointestinal disease], trauma [submersion, distress], alcohol intoxication, other [including drugs]), Charlson comorbidity index (CCI) [10], Glasgow coma scale (GCS) [11], Sequential Organ Failure Assessment (SOFA) score [12], laboratory data, temperature, blood pressure, heart rate, respiratory rate, cardiac arrest during pre-hospital, intubation, hospital length of stay, mortality, and Cerebral Performance Category (CPC) [13] score at 30 days after admission, and complications. The temperature was recorded as the core temperature from the rectum, urinary bladder, or esophagus if available; otherwise, the peripheral temperature from the axilla or ear was noted. The severity of hypothermia was classified according to the temperature as mild (35–32 °C), moderate (32–28 °C), or severe (< 28 °C) with reference to previous studies [1] [3].
The laboratory data included the pH value, potassium level, lactate level, platelet count, CPK level, BUN level, and creatinine level measured at the ED. The pH value in principle was evaluated by an arterial blood gas analysis, and the pH value measured using the venous blood gas was adjusted as described in a previous study [14]. In the present study, the patients who did not stay in a hospital, or in whom the length of hospital stay or body temperature was unknown or > 35 °C were excluded from the present analysis.
Anzeige
Complications during hospitalization were recorded and classified as arrhythmia, pneumonia, pancreatitis, electrolyte abnormality, or other. Pneumonia was defined as an obvious shadow on chest radiography or computed tomography (CT). Pancreatitis was defined as cases meeting at least two of the following conditions: 1) abdominal pain, 2) elevation of pancreatic enzyme levels in the blood, and 3) edema of the pancreas or peripancreatic effusion on ultrasound/CT.
The rewarming duration to target temperature was defined as the time interval between arrival at the ED and the moment at which the target temperature was reached. The rewarming rate (°C per hour) was defined as follows: (target temperature-temperature at ED) / the rewarming duration to target temperature.
Rewarming methods were divided into active external rewarming (warmed blanket, forced warm air, heating pad, and warmed bath) and active internal rewarming (warmed fluid infusion, lavage, hemodialysis, intravascular catheter, and extracorporeal membrane oxygenation [ECMO]).
Definition of frailty
The clinical frailty scale (CFS) score was used to determine the presence and degree of frailty, as described previously [15]. The CFS score was determined using the activities of daily living and pre-existing conditions, as shown in our previous study [16]: CFS 1, very fit, defined as ADL 1 (independent) and CCI 0; CFS 2, well, defined as ADL 1 and CCI ≥1, or ADL 2 (sometimes out of the door) and CCI 0; CFS 3, well with treated comorbid disease, defined as ADL 2 and CCI 1–2; CFS 4, apparently vulnerable, defined as ADL 2 and CCI ≥3, or ADL 3 (indoors); CFS 5, mildly frail, defined as ADL 4 (almost needing assistance) and CCI ≤2; CFS 6, moderately frail, defined as ADL 4 and CCI ≥3; and CFS 7, severely frail, defined ADL 5 (needing total assistance). Patients were defined as frail if they had a CFS score of ≥5 before hospital admission.
Outcome measures
Patient demographics and outcomes were compared between frail and non-frail patients. The primary outcome was the comparison of mortality between the frail and non-frail patient groups. The secondary outcomes were the comparisons of the length of intensive care unit (ICU) stay, hospital stay, CPC at 30 days after admission, and complications between the frail and non-frail patient groups. A favorable outcome was defined as a CPC of 1 or 2, whereas an unfavorable outcome was defined as a CPC 3–5.
Data analyses
Data are expressed as the number (%), median (interquartile range) or the mean ± standard deviation, as appropriate. Intergroup comparisons were made using the Fisher’s exact test for categorical data and Mann-Whitney U test or Student’s t-test for continuous data. Ninety-day survival was calculated using a Kaplan-Meier curve and the difference in survival between frail and non-frail patients was determined using a log-rank test. Hazard ratios (HRs) and the corresponding 95% confidence intervals (CI) of the association between frailty and 90-day survival were derived using Cox proportional hazard survival models. The following covariates were included in the multivariable model based on the relevant literature [2, 3], or the consideration of clinically significant variables: age, sex, potassium level, lactate level, pH value, CPK level, heart rate, platelet count, location of hypothermia incidence, and rate of tracheal intubation. Missing data were managed with multiple imputation by chained equations [17, 18]. The variables included in the imputation model were those from the multivariable model. Twenty-five datasets were imputed with 10 iterations each. A Cox proportional hazards analysis was applied to the 25 imputed datasets, and final estimates were obtained by averaging the 25 estimates according to Rubin’s rules. Furthermore, a complete data set was used for the sensitivity analysis. We also performed a subgroup analysis with the exclusion of cases in which a warmed blanket or ECMO were applied. All tests were two-sided, and P values of < 0.05 were considered statistically significant. All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), a graphical user interface for the R software program. Multiple imputation was performed using the mice package in R (version, 4.0.3 R Foundation for Statistical Computing, Vienna, Austria).
Results
Of the 1363 patients with hypothermia who were included in the Hypothermia STUDY 2018&2019, 443 were excluded from the present study because of unknown temperature or temperature > 35 °C (N = 147), unknown outcome (N = 127), unknown length of hospital stay (N = 150), or unknown ADL (N = 19). The remaining 920 patients were eligible for inclusion in the present analysis. A patient flow diagram is shown in Fig. 1. According to the CFS score, the 920 patients were divided into the frail patient group (N = 221) and the non-frail patient group (N = 699).
Fig. 1
Flow chart of the enrolment of the study participants. Of the 1363 patients with hypothermia, 920 patients were enrolled, and 443 patients were excluded. The 920 patients were divided into the frail group (N = 221) and the non-frail group (N = 699). ED, emergency department; CFS, clinical frailty scale
×
Baseline characteristics of the study population
Supplemental Fig. 1 shows the age distribution of the patients included in the present study. The present population included only a few relatively young patients, with 81% of the total patients being ≥65 years old, and the median patient age being 79 years old. Table 1 shows the baseline characteristics of the study population and a comparison of the clinical characteristics of frail and non-frail patients. The non-frail patient group had a larger percentage of male in comparison to the frail patient group. The frail patient group was older, had higher CCI values, and included a higher percentage of AH cases that occurred indoors in comparison to the non-frail patient group. Regarding the mechanism of hypothermia, the rate of acute medical illness in the frail patient group was higher than that in the non-frail patient group.
Table 1
Baseline characteristics
All patients
Missing
Frail
Non-Frail
p-value
n = 920
n, (%)
n = 221
n = 699
Age, years
79 (68–87)
0
85 (78–90)
77 (66–86)
< 0.001
Male
513 (55.8%)
0
105 (47.5%)
408 (58.4%)
< 0.001
Charlson comorbidity indexa
1 (0–2) 1.2 ± 1.6
0
1 (0–2) 1.5 ± 1.7
1 (0–2) 1.1 ± 1.5
< 0.001
Severity
SOFA total
6 (3–8)
71 (7.7)
6 (4–8)
5 (3–8)
0.286
Clinical Frailty Scale score
2 (1–4)
0
5 (5–7)
2 (1–3)
< 0.001
Lifestyle
10 (1.1)
< 0.001
Living alone
298 (32.4%)
39 (17.8%)
259 (37.5%)
Not living alone
549 (59.7%)
144 (65.8%)
405 (58.6%)
Homelessness
3 (0.3%)
0 (0.0%)
3 (0.4%)
Nursing home
48 (5.2%)
34 (15.5%)
14 (2.0%)
Unknown
12 (1.3%)
2 (0.9%)
10 (1.4%)
Location of hypothermia incidence
24 (2.6)
< 0.001
Outdoor
218 (23.7%)
14 (6.5%)
204 (30%)
Indoor
678 (73.7%)
203 (93.5%)
475 (70%)
Hypothermia caused mechanism
57 (6.2)
< 0.001
Acute medical illness
465 (50.5%)
123 (60.6%)
342 (51.8%)
Trauma, Submersion, and distress
126 (13.7%)
17 (8.4%)
109 (16.5%)
Alcohol intoxication
41 (4.5%)
3 (1.5%)
38 (5.8%)
Others (Unknown, drug)
231 (25.1%)
60 (29.6%)
171 (25.9%)
SOFA Sequential Organ Failure Assessment; The data are expressed as the number (%), median (interquartile range) or mean ± standard deviation
aThe values were presented as the median and 25th–75th percentile because the Charlson comorbidity index showed a skewed distribution. However, these values were the same in the frail and non-frail groups despite the Mann-Whitney U test showing significance, so the mean and standard deviation are shown as well
Anzeige
Clinical and laboratory data
Among the 920 patients, the core body temperature was measured in 585 (63.6%). The clinical and laboratory data are presented in Table 2. There were no significant differences in the severity grade of temperature, blood pressure, respiratory rate, potassium level, creatinine level, or cardiac arrest during the pre-hospital period between frail and non-frail patients. Frail patients had a lower GCS, heart rate, lactate level, platelet count, CPK level, and rate of tracheal intubation in comparison to non-frail patients. The pH values of frail patients were significantly higher in comparison to non-frail patients.
Table 2
Clinical and laboratory data of the patients with hypothermia
All patients
Missing
Frail
Non-Frail
p-value
n = 920
n, (%)
n = 221
n = 699
Temperature
30.6 (28.2–33.1)
0
30.6 (28.6–33.0)
30.6 (28.1–33.2)
0.810
Mild (35–32 °C)
348 (37.8%)
81 (36.7%)
267 (38.2%)
0.081
Moderate (32–28 °C)
360 (39.1%)
99 (44.8%)
261 (37.3%)
Severe (< 28 °C)
212 (23.0%)
41 (18.6%)
171 (24.5%)
GCS
10 (7–14)
50 (5.4)
10 (7–13)
11 (7–14)
< 0.001
Systolic BP (mmHg)
117 (90–146)
82 (8.9)
115 (90–143)
117 (91–147)
0.705
Diastolic BP (mmHg)
68 (51–86)
96 (10.4)
67 (51–82)
69 (51–88)
0.454
Heart rate
72 (53–90)
30 (3.3)
62 (48–82)
73 (56–92)
< 0.001
Respiratory rate
18 (15–22)
89 (9.7)
18 (15–21)
18 (15–23)
0.423
pH
7.30 (7.19–7.37)
61 (6.6)
7.32 (7.23–7.39)
7.29 (7.18–7.37)
< 0.001
Potassium (mEq/L)
4.2 (3.7–4.9)
7 (0.8)
4.3 (3.7–4.9)
4.2 (3.7–4.9)
0.674
Lactate (mmol/L)
3.5 (1.8–7.6)
121 (13.2)
2.3 (1.1–6.8)
3.8 (2.0–8.2)
< 0.001
Plt (× 104/μL)
18.1 (12.6–24.3)
13 (1.4)
16.1 (10.9–22.3)
18.7 (13.3–24.7)
< 0.001
CPK (U/L)
347 (138–1239)
72 (7.8)
249 (104–617)
393 (150–1494)
< 0.001
BUN (mg/dL)
31.7 (19.3–55.0)
13 (1.4)
35.1 (22.0–57.0)
30.4 (18.5–54.2)
0.020
Creatinine (mg/dL)
1.1 (0.7–1.8)
14 (1.5)
1.1 (0.7–1.9)
1.1 (0.7–1.8)
0.736
CPA
62 (6.7%)
2 (0.2)
12 (5.5%)
50 (7.2%)
0.443
Intubation
157 (17.1%)
60 (6.5)
23 (11.4%)
134 (20.3%)
< 0.001
GCS Glasgow Coma Scale, CPA cardiopulmonary arrest
The data are expressed as the number (%), median (interquartile range)
Primary outcome
As shown in Table 3, the overall 30-day mortality rate was 23.5% (N = 216). After 30 days of hospitalization, 32.6% of frail patients and 20.6% of non-frail patients had died (p < 0.001). A survival time analysis revealed that there was significant difference between frail and non-frail patients (log-rank test p < 0.001) (Fig. 2). The results of the Cox proportional hazards analysis are summarized in Table 4. In the unadjusted analysis, frail patients had a significantly higher risk of 90-day mortality (Hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.25–2.17; p < 0.001). Based on the Cox proportional hazards analysis using multiple imputation, after adjustment for age, potassium level, lactate level, pH value, sex, CPK level, heart rate, platelet count, location of hypothermia incidence, and rate of tracheal intubation, frail patients still had a significantly higher risk of 90-day mortality (Hazard ratio [HR], 1.69; 95% confidence interval [CI], 1.25–2.29; p < 0.001). A sensitivity analysis performed using the complete dataset of cases excluding cases with missing values (N = 679) confirmed the robustness of the results.
Table 3
Mortality, hospital length of stay, neurological score, and complications
All patients
Frail
Non-Frail
p-value
n = 920
n = 221
n = 699
30-day mortality
216 (23.5%)
72 (32.6%)
144 (20.6%)
< 0.001
Length of stay at ICU
3 (2–6)
3 (2–5)
4 (2–7)
0.090
Length of stay at hospital
13 (4–27)
11 (3–23)
13 (4–29)
0.081
CPC at 30 days
< 0.001
good (1–2)
302
27 (20.0%)
275 (57.2%)
poor (3–5)
314
108 (80.0%)
206 (42.8%)
Complication
Arrhythmia
22
6 (2.7%)
16 (2.3%)
0.800
Pneumonia
5
2 (0.9%)
3 (0.4%)
0.599
Pancreatitis
1
1 (0.5%)
0 (0%)
0.240
Electrolyte abnormalities
3
0 (0%)
3 (0.4%)
1.000
Coagulopathy
5
2 (0.9%)
3 (0.4%)
0.599
Other
10
6 (2.7%)
4 (0.6%)
0.016
ICU Intensive care unit, CPC Cerebral Performance Category
The data are expressed as the number (%), median (interquartile range)
Fig. 2
Probability of survival in patients with accidental hypothermia. Statistical comparison of survival of frail and non-frail patients, according to the Kaplan-Meier method
Table 4
The comparison of mortality in frail and non-frail patients with hypothermia (multivariate Cox regression analysis)
Variable
HR
95% CI
P-value
Frail (Model 1)
1.64
1.25–2.17
< 0.001
Multiple imputation model (N = 920)
Fraila (Model 2)
1.69
1.25–2.29
< 0.001
Complete data set model (N = 679)
Frailb (Model 3)
1.45
1.01–2.09
0.043
HR Hazard ratio, CI Confidence interval
aAfter multiple imputation, adjusted for age, potassium, lactate, pH, sex, CPK, heart rate, platelet, location of hypothermia incidence, and rate of tracheal intubation
bAdjusted for age, potassium, lactate, pH, sex, CPK, heart rate, platelet, location of hypothermia incidence, and rate of tracheal intubation
×
Secondary outcomes
Among the 920 total patients, the median length of ICU stay was 3 days, and the median length of hospital stay was 13 days. There was no significant difference in the length of stay at the ICU or hospital between frail and non-frail patients (Table 3). However, in the neurological assessment, frail patients showed a higher rate of patients with a worsened neurological score (CPC 3–5) at 30 days after admission in comparison to non-frail patients, while non-frail patients showed a significantly higher rate of patients with a favorable neurological outcome (CPC 1–2) in comparison to frail patients. There was no significant difference in the incidence of complications between the frail and non-frail patient groups.
Rewarming method and rewarming rate
The rewarming method and rewarming rate are presented in Table 5. The rates of warmed blanket (P < 0.001) and ECMO (P = 0.039) use in the frail patient group were lower in comparison to the non-frail patient group. However, the other rewarming methods did not differ between the two groups to a statistically significant extent. The rewarming rate in frail patients was significantly slower than that in non-frail patients (p < 0.001).
Table 5
Rewarming method and rewarming rate
Frail
Non-Frail
p-value
n = 221
n = 699
Rewarming method
Active external rewarming
Warmed blanket
73 (33.6%)
156 (22.8%)
< 0.001
Forced warm air
130 (59.9%)
381 (55.8%)
0.307
Heating pad
4 (1.8%)
34 (5.0%)
0.052
Warmed bath
4 (1.8%)
15 (2.2%)
1.000
Active internal rewarming
Warmed fluid infusion
144 (66.4%)
459 (67.2%)
0.868
Lavage
4 (1.8%)
17 (2.5%)
0.797
Hemodialysis
2 (0.9%)
8 (1.2%)
1.000
Intravascular catheter
3 (1.4%)
14 (2.0%)
0.775
ECMO
3 (1.4%)
30 (4.4%)
0.039
Rewarming rate (°C/h)
0.96 (0.62–1.30)
1.13 (0.74–1.54)
< 0.001
ECMO Extracorporeal membrane oxygenation
The data are expressed as the number (%), median (interquartile range)
Anzeige
Subgroup analyses
In the subgroup analysis with the exclusion of cases in which a warmed blanket or ECMO were applied, the rewarming rate in frail patients was still lower than that in non-frail patients (Supplemental Table 1).
Discussion
The present nationwide study showed that frail patients with AH had a significantly higher risk of mortality in comparison to non-frail patients with AH, even after adjustment for important confounders. Additionally, the frail patient group included a higher rate of patients with a worsened neurological outcome in comparison to the non-frail patient group. The rewarming rate in frail patients was delayed in comparison to non-frail patients.
Recently, frailty has been shown to be associated with mortality and adverse outcomes in patients with various conditions [7], including patients with chronic obstructive pulmonary disease [19], patients with inflammatory bowel disease [20], patients with AIDS [21], patients awaiting liver transplantation [22], hip fracture patients [23] and patients undergoing elective vascular surgery [24], independent of chronological age. However, whether or not frailty is associated with mortality in patients with AH has not previously been investigated. The present nationwide study showed, for the first time, that frailty is an important prognostic factor in patients with AH.
Previous studies showed that prognostic factors in AH include the potassium level, pH value, lactate level, and age [2, 3, 25‐27]. Although these factors may be useful for predicting the prognosis and selecting an appropriate rewarming intervention, these factors cannot be controlled and do not help improve the prognosis of patients with AH. However, in contrast to the other factors, frailty is a factor that can be avoided with preventive intervention [28] [29]. The reduction of frailty might consequently lead to a decrease in the number of deaths caused by AH.
Anzeige
The rewarming rate in frail patients was slower than that in non-frail patients. Although the rates at which ECMO or a warmed blanket were used in the frail patient group were lower in comparison to the non-frail patient group, the results were also similar in the subgroup analysis that excluded cases in which ECMO or a warmed blanket were used. The reasons for the difference in the rewarming rate may be as follows. It is hypothesized that intrinsic heat production by the patient, such as shivering thermogenesis, does not occur sufficiently in frail patients with AH, resulting in delayed rewarming. In the present study, the finding that the CPK level was lower in the frail patient group may support this mechanism. A previous study showed that a decreased rewarming rate in patients with AH is associated with a high risk of underlying infection [30] and mortality [31]. In recent years, many studies have shown that the prognosis of septic patients with hypothermia is poor [32‐34]. For this reason, it has been pointed out that homeostatic dysfunction, such as immune dysfunction, is related to the poor prognosis of these patients [35, 36]. Although there was no significant difference in the occurrence of infectious complications between the frail and non-frail patient groups in the present study, a similar mechanism may be responsible for the relationship between frailty and a poor prognosis in patients with AH. On the other hand, the results of this study could not clarify whether or not the rapid rewarming using invasive internal rewarming methods will reduce mortality and improve the prognosis of frail patients with AH. Thus, further studies are needed to address this problem.
In our previous study, we found that frail patients with AH showed prolonged hospitalization [16]. However, in this study, there was no significant difference in the length of hospital stay between the frail and non-frail patient groups. The reasons are as follows: the previous study excluded patients who died within 30 days, whereas the present study included these patients. The rate of early mortality within 30 days was higher in the frail group than in the non-frail group. As a result, the length of hospital stay in the frail group was shorter than that in the non-frail group, although the difference was not statistically significant.
A previous study showed that, among ICU patients requiring mechanical ventilation, the presence of frailty increased the likelihood of short-term mortality, and that these findings might play a role in informed shared decision-making with patients and families prior to the provision of mechanical ventilation [37]. In this study, the rate of tracheal intubation was lower among frail patients than among non-frail patients. This may be because these patients and their families did not wish to receive invasive treatment with intubation and ventilation.
Regarding complications, previous studies have reported that the incidence of complications is higher in frail patients [7]. However, in this study, the incidence of complications in the frail and non-frail patient groups did not differ to a statistically significant extent. The complications defined in this study (arrhythmia, pneumonia, pancreatitis, electrolyte abnormality and coagulopathy) occurred infrequently, which may have contributed to the lack of a significant difference.
The present study was associated with some limitations. First, we used the CFS score, which was calculated based on ADL and the CCI to determine frailty, while the standard tools for the diagnosis of frailty are the frailty index [38] or frailty phenotype [39]. Therefore, it remains to be verified whether the diagnosis of frailty in this study was accurate. In this regard, a comparative study regarding the accuracy of the CFS score is currently in progress [40]. Second, there were numerous missing data in relation to the rewarming rate. However, the volume of data including in this nationwide study was sufficient; thus, the results are considered robust. Third, we could not to determine the rewarming rate according to individual rewarming methods, because several rewarming methods were used in combination. Finally, this study was based on the findings of registry data on hypothermia, and it did not include any data that was related to frail research, such as ADL after a long-term follow-up. Therefore, further studies will be needed to investigate the long-term ADL of frail patients with AH.
Conclusions
This study found that, after adjustment for multiple factors, mortality in frail patients with AH was higher than that in non-frail patients with AH. According to the neurological outcome after 30 days, the percentage of patients with a poor prognosis in the frail patient group was higher than that in the non-frail patient group. It is important to recognize that frail patients with AH are at risk for more severe hypothermia.
Acknowledgements
Aidu Chuo Hospital.
Aizawa Hospital.
Akita Red Cross Hospital.
Aomori Prefectural Central Hospital.
Asahikawa City Hospital.
Asahikawa Medical University Hospital.
Asahikawa Red Cross Hospital.
Center Hospital of the National Center for Global Health and Medicine.
Chiba Emergency Medical Center.
Chikamori Hospital.
Daiyukai General Hospital.
Dokkyo Medical University Nikko Medical Center.
Dokkyo Medical University Saitama Medical Center.
Eastern Chiba Medical Center.
Ehime Prefectural Niihama Hospital.
Esashi Hospital.
Fujieda Municipal General Hospital.
Fujisawa City Hospital.
Fukui Prefectural Hospital.
Fukuoka University Hospital.
Fukushima Medical University Hospital.
Funabashi Municipal Medical Center.
Gifu Prefectural General Medical Center.
Gifu University Hospital.
Hachinohe City Hospital.
Hamamatsu Medical Center.
Hidaka Tokushukai Hospital.
Hiroshima Prefectural Hospital.
Hokkaido Medical Center.
Hyogo Emergency Medical Center.
Hyogo Prefectural Nishinomiya Hospital.
Ina Central Hospital.
Ise Red Cross Hospital.
Ishikawa Prefectural Central Hospital.
Ishinomaki Red Cross Hospital.
Iwata City Hospital.
Iwate Prefectural Central Hospital.
JA Onomichi General Hospital.
Japanese Red Cross Society Kyoto Daiichi Hospital.
Jichi Medical University Saitama Center.
Jikei University Daisan Hospital.
Juntendo University Nerima Hospital.
Juntendo University Urayasu Hospital.
Kagawa University Hospital.
Kansai Medical University Hospital.
Kasugai Municipal Hospital.
Kawaguchi Municipal Medical Center.
Kawasaki Municipal Hospital.
Kimitsu Chuo Hospital.
Kishiwada Tokushukai Hospital.
Kitakyushu General Hospital.
Kumamoto Red Cross Hospital.
Kushiro City General Hospital.
Kyorin University Hospital.
Kyoto University Hospital.
Maebashi Red Cross Hospital.
Mie Prefectural General Medical Center.
Mie University Hospital.
Miyazaki Prefectural Nobeoka Hospital.
Nagano Red Cross Hospital.
Nagasaki University Hospital.
Nagoya Ekisaikai Hospital.
Nagoya University Hospital.
Narita Red Cross Hospital.
Nasu Red Cross Hospital.
National Defense Medical College Hospital.
National Hospital Organization Mito Medical Center.
National Hospital Organization Nagoya Medical Center.
National Hospital Organization Osaka National Hospital.
National Hospital Organization Yokohama Medical Center.
Nayoro City General Hospital.
Nihon University Hospital.
Nihon University Itabashi Hospital.
Nihonkai General Hospital.
Niigata University Medical & Dental Hospital.
Nippon Medical School Hospital.
Nippon Medical School Tamanagayama Hospital.
Oita University Hospital.
Okinawa Prefectural Nanbu Medical Center & Children’s Medical Center.
Okitama Public General Hospital.
Ome Municipal Central Hospital.
Omihachiman Community Medical Center.
Osaka City General Hospital.
Ota Memorial Hospital.
Rinku General Medical Center.
Saiseikai Shiga Hospital.
Saiseikai Utsunomiya Hospital.
Sapporo City General Hospital.
Sapporo Medical University Hospital.
Seirei Hamamatsu General Hospital.
Seirei Mikatahara General Hospital.
Shinshu University Hospital.
Shizuoka Red Cross Hospital.
Shonan Kamakura General Hospital.
St.Mary’s Hospital.
Steel Memorial Hirohata Hospital.
Sunagawa City Medical Center.
Takasaki General Medical Center.
Teikyo University Hospital.
Teine Keijinkai Hospital.
Tenshi Hospital.
Toho University Omori Medical Center.
Tohoku University Hospital.
Tokai University Hospital.
Tokushima Prefectural Miyoshi Hospital.
Tokuyama Central Hospital.
Tokyo Metropolitan Tama Medical Center.
Tosei General Hospital.
Toyama University Hospital.
Tsuyama Chuo Hospital.
Uji Tokushukai Medical Center.
University of Tokyo Hospital.
University of Yamanashi Hospital.
Wakayama Red Cross Medical Center.
Yamagata Prefectural Central Hospital.
Yamagata University Hospital.
Yamaguchi University Hospital.
Yamanashi Prefectural Central Hospital.
Yokkaichi Municipal Hospital.
Yokohama Minami Kyosai Hospital.
Declarations
Ethics approval and consent to participate
This study has been confirmed that all the experiments were performed in accordance with relevant guidelines and regulations. The study has been approved by the Ethics Review Board of Teikyo University Hospital in Japan (Approval No: 17–090). The requirement for informed consent was waived due to the observational nature of the study by the Ethics Review Board of Teikyo University Hospital in Japan. In addition, the institutional review board of each hospital listed in the acknowledgements approved the study.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests in association with the present study.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.
Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.
Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.
Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
